232 related articles for article (PubMed ID: 32497830)
41. Gold Nanoclusters as Nanoantibiotic Auranofin Analogues.
Ndugire W; Raviranga NGH; Lao J; Ramström O; Yan M
Adv Healthc Mater; 2022 May; 11(9):e2101032. PubMed ID: 34350709
[TBL] [Abstract][Full Text] [Related]
42. Broad Spectrum Functional Activity of Structurally Related Monoanionic Au(III) Bis(Dithiolene) Complexes.
Le Gal Y; Filatre-Furcate A; Lorcy D; Jeannin O; Roisnel T; Dorcet V; Fontinha D; Francisco D; Prudncio M; Martins M; Soeiro C; Sousa SA; Leitão JH; Morais TS; Bártolo I; Taveira N; Guerreiro JF; Marques F
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806151
[TBL] [Abstract][Full Text] [Related]
43. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
Liu W; Bensdorf K; Proetto M; Abram U; Hagenbach A; Gust R
J Med Chem; 2011 Dec; 54(24):8605-15. PubMed ID: 22091836
[TBL] [Abstract][Full Text] [Related]
44. Cytotoxic Ag(I) and Au(I) NHC-carbenes bind DNA and show TrxR inhibition.
Guarra F; Busto N; Guerri A; Marchetti L; Marzo T; García B; Biver T; Gabbiani C
J Inorg Biochem; 2020 Apr; 205():110998. PubMed ID: 31981769
[TBL] [Abstract][Full Text] [Related]
45. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.
Wang H; Bouzakoura S; de Mey S; Jiang H; Law K; Dufait I; Corbet C; Verovski V; Gevaert T; Feron O; Van den Berge D; Storme G; De Ridder M
Oncotarget; 2017 May; 8(22):35728-35742. PubMed ID: 28415723
[TBL] [Abstract][Full Text] [Related]
46. A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt
Chiaverini L; Baglini E; Mannelli M; Poggetti V; Da Settimo F; Taliani S; Gamberi T; Barresi E; La Mendola D; Marzo T
Biometals; 2023 Oct; 36(5):961-968. PubMed ID: 36869967
[TBL] [Abstract][Full Text] [Related]
47. Auranofin and N-heterocyclic carbene gold-analogs are potent inhibitors of the bacteria Helicobacter pylori.
Owings JP; McNair NN; Mui YF; Gustafsson TN; Holmgren A; Contel M; Goldberg JB; Mead JR
FEMS Microbiol Lett; 2016 Jul; 363(14):. PubMed ID: 27279627
[TBL] [Abstract][Full Text] [Related]
48. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches.
Karaca Ö; Scalcon V; Meier-Menches SM; Bonsignore R; Brouwer JMJL; Tonolo F; Folda A; Rigobello MP; Kühn FE; Casini A
Inorg Chem; 2017 Nov; 56(22):14237-14250. PubMed ID: 29095609
[TBL] [Abstract][Full Text] [Related]
49. From Catalysis to Cancer: Toward Structure-Activity Relationships for Benzimidazol-2-ylidene-Derived N-Heterocyclic-Carbene Complexes as Anticancer Agents.
Lam NYS; Truong D; Burmeister H; Babak MV; Holtkamp HU; Movassaghi S; Ayine-Tora DM; Zafar A; Kubanik M; Oehninger L; Söhnel T; Reynisson J; Jamieson SMF; Gaiddon C; Ott I; Hartinger CG
Inorg Chem; 2018 Nov; 57(22):14427-14434. PubMed ID: 30406647
[TBL] [Abstract][Full Text] [Related]
50. Metal complexes with 2-acetylpyridine-N(4)-orthochlorophenylthiosemicarbazone: cytotoxicity and effect on the enzymatic activity of thioredoxin reductase and glutathione reductase.
Parrilha GL; Ferraz KS; Lessa JA; de Oliveira KN; Rodrigues BL; Ramos JP; Souza-Fagundes EM; Ott I; Beraldo H
Eur J Med Chem; 2014 Sep; 84():537-44. PubMed ID: 25058344
[TBL] [Abstract][Full Text] [Related]
51. Selection and characterization of a human ovarian cancer cell line resistant to auranofin.
Landini I; Lapucci A; Pratesi A; Massai L; Napoli C; Perrone G; Pinzani P; Messori L; Mini E; Nobili S
Oncotarget; 2017 Nov; 8(56):96062-96078. PubMed ID: 29221187
[TBL] [Abstract][Full Text] [Related]
52. Design and synthesis of benzylidenecyclohexenones as TrxR inhibitors displaying high anticancer activity and inducing ROS, apoptosis, and autophagy.
Qian J; Xu Z; Meng C; Liu J; Hsu PL; Li Y; Zhu W; Yang Y; Morris-Natschke SL; Lee KH; Zhang Y; Ling Y
Eur J Med Chem; 2020 Oct; 204():112610. PubMed ID: 32736231
[TBL] [Abstract][Full Text] [Related]
53. The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation.
Cox AG; Brown KK; Arner ES; Hampton MB
Biochem Pharmacol; 2008 Oct; 76(9):1097-109. PubMed ID: 18789312
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, characterization, and in vitro studies of bis[1,3-diethyl-4,5-diarylimidazol-2-ylidene]gold(I/III) complexes.
Liu W; Bensdorf K; Proetto M; Hagenbach A; Abram U; Gust R
J Med Chem; 2012 Apr; 55(8):3713-24. PubMed ID: 22424185
[TBL] [Abstract][Full Text] [Related]
55. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ
Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278
[TBL] [Abstract][Full Text] [Related]
57. Cinnamaldehydes inhibit thioredoxin reductase and induce Nrf2: potential candidates for cancer therapy and chemoprevention.
Chew EH; Nagle AA; Zhang Y; Scarmagnani S; Palaniappan P; Bradshaw TD; Holmgren A; Westwell AD
Free Radic Biol Med; 2010 Jan; 48(1):98-111. PubMed ID: 19837157
[TBL] [Abstract][Full Text] [Related]
58. Redox proteome analysis of auranofin exposed ovarian cancer cells (A2780).
Chiappetta G; Gamberi T; Faienza F; Limaj X; Rizza S; Messori L; Filomeni G; Modesti A; Vinh J
Redox Biol; 2022 Jun; 52():102294. PubMed ID: 35358852
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: Organoselenium compounds for cancer therapy.
He J; Li D; Xiong K; Ge Y; Jin H; Zhang G; Hong M; Tian Y; Yin J; Zeng H
Bioorg Med Chem; 2012 Jun; 20(12):3816-27. PubMed ID: 22579620
[TBL] [Abstract][Full Text] [Related]
60. [Potential Anticancer Activity of Auranofin].
Momose I; Onodera T; Kawada M
Yakugaku Zasshi; 2021; 141(3):315-321. PubMed ID: 33642497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
